This cohort study describes the clinical outcomes of women with BRCA1/2 variant–associated breast cancer who were treated with breast-conserving therapy, including the risk of ipsilateral and contralateral cancer events and bilateral mastectomy-free survival. This evidence concerns the gene BRCA1 and breast cancer.